Drug Shortage Report for TEVA-PINDOLOL
| Report ID | 143265 |
| Drug Identification Number | 00869007 |
| Brand name | TEVA-PINDOLOL |
| Common or Proper name | PINDOLOL 5MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | PINDOLOL |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | C07AA |
| ATC description | BETA BLOCKING AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2021-07-26 |
| Estimated end date | 2021-09-30 |
| Actual end date | 2021-09-01 |
| Shortage status | Resolved |
| Updated date | 2021-09-02 |
| Company comments | Item will be allocated to 100% of Teva market for shortage period |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-09-02 | French | Compare |
| v4 | 2021-09-02 | English | Compare |
| v3 | 2021-07-29 | French | Compare |
| v2 | 2021-07-29 | English | Compare |
| v1 | 2021-07-29 | English | Compare |
Showing 1 to 5 of 5